Enrique Lores - 08 Dec 2022 Form 4 Insider Report for HP INC (HPQ)

Signature
/s/ Rick Hansen as Attorney-in-Fact for Enrique Lores
Issuer symbol
HPQ
Transactions as of
08 Dec 2022
Net transactions value
$0
Form type
4
Filing time
12 Dec 2022, 19:17:29 UTC
Previous filing
09 Dec 2022
Next filing
05 Jan 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HPQ Restricted Stock Units Award +180,126 180,126 08 Dec 2022 Common Stock 180,126 Direct F1, F2
transaction HPQ Performance Adjusted Restricted Stock Units Award +179,261 179,261 08 Dec 2022 Common Stock 179,261 Direct F3, F4
transaction HPQ Performance Contingent Stock Options Award +634,503 634,503 08 Dec 2022 Common Stock 634,503 $28.48 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
F2 On 12/8/2022, the reporting person was granted 180,126 RSUs, 1/3 of which vest annually over 3 years on the anniversary of 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
F3 Each performance adjusted restricted stock unit ("PARSU") represents a contingent right to receive one share of HP common stock.
F4 On 12/8/2022, the reporting person was granted 179,261 PARSUs, which will only be earned after certification of financial results as of October 31, 2025, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Depending on the level of achievement of such goals, the actual number of PARSUs earned can range from 0% to 300% of the target number of PARSUs shown in column 5. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
F5 On 12/8/2022, the reporting person was granted 634,503 performance contingent stock options, 1/3 of which vest annually over 3 years on the anniversary of the grant date, in each case subject to the satisfaction of certain stock price performance conditions.